This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Carling, T. Articles by Westin, G. Search for Related Content PubMed PubMed Citation Articles by Carling, T. Articles by Westin, G.

Vitamin D Receptor (VDR) and Parathyroid Hormone Messenger Ribonucleic Acid Levels Correspond to Polymorphic VDR Alleles in Human Parathyroid Tumors¹

Department of Surgery, Endocrine Unit, Uppsala University Hospital, S-751 85 Uppsala, Sweden

Address all correspondence and requests for reprints to: Tobias Carling, Ph.D., Department of Surgery, Endocrine Unit, Uppsala University Hospital, S-751 85 Uppsala, Sweden. E-mail: tobias.carling{at}kirurgi.uu.se

Calcitriol, via its receptor (VDR) is a main regulator of PTH secretion and parathyroid cell proliferation. Recently, marked overrepresentation of the polymorphic VDR alleles b, a, and T was found in patients with primary hyperparathyroidism (pHPT), which suggests pathogenic importance in the disease. Using the ribonuclease protection assay, relative VDR and PTH messenger ribonucleic acid (mRNA) levels of parathyroid adenomas from 42 patients with sporadic pHPT were related to these VDR polymorphisms. The tumors of patients homozygous for the b, a, or T alleles demonstrated significantly lower VDR and higher PTH mRNA levels than those exhibiting the BB, AA, or tt genotypes (P < 0.0001–0.02), whereas heterozygotes had intermediate values. A similar discrepancy was found when comparing the baT and non-baT haplotypes (0.042 ± 0.005 vs. 0.064 ± 0.004 for VDR; 34.4 ± 3.7 vs. 21.6 ± 2.2 for PTH; both P < 0.005). The lower VDR mRNA levels associated with the b, a, and T alleles may affect the calcitriol-mediated control of parathyroid function and thereby contribute to the development of sporadic pHPT.

This article has been cited by other articles:

				I.-L. Nilsson, J. Zedenius, L. Yin, and A. Ekbom The association between primary hyperparathyroidism and malignancy: nationwide cohort analysis on cancer incidence after parathyroidectomy Endocr. Relat. Cancer, March 1, 2007; 14(1): 135 - 140. [Abstract] [Full Text] [PDF]

				J. Han, G. A. Colditz, and D. J. Hunter Polymorphisms in the MTHFR and VDR genes and skin cancer risk Carcinogenesis, February 1, 2007; 28(2): 390 - 397. [Abstract] [Full Text] [PDF]

				E. H. Samander and A. Arnold Mutational Analysis of the Vitamin D Receptor Does Not Support Its Candidacy as a Tumor Suppressor Gene in Parathyroid Adenomas J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 5019 - 5021. [Abstract] [Full Text] [PDF]

				A. H. Poon, C. Laprise, M. Lemire, A. Montpetit, D. Sinnett, E. Schurr, and T. J. Hudson Association of Vitamin D Receptor Genetic Variants with Susceptibility to Asthma and Atopy Am. J. Respir. Crit. Care Med., November 1, 2004; 170(9): 967 - 973. [Abstract] [Full Text] [PDF]

				B.-W. Ogunkolade, B. J. Boucher, J. M. Prahl, S. A. Bustin, J. M. Burrin, K. Noonan, B. V. North, N. Mannan, M. F. McDermott, H. F. DeLuca, et al. Vitamin D Receptor (VDR) mRNA and VDR Protein Levels in Relation to Vitamin D Status, Insulin Secretory Capacity, and VDR Genotype in Bangladeshi Asians Diabetes, July 1, 2002; 51(7): 2294 - 2300. [Abstract] [Full Text] [PDF]

				C-M Huang, M-C Wu, J-Y Wu, and F-J Tsai Association of vitamin D receptor gene BsmI polymorphisms in Chinese patients with systemic lupus erythematosus Lupus, January 1, 2002; 11(1): 31 - 34. [Abstract] [PDF]

				Y. Ban, M. Taniyama, and Y. Ban Vitamin D Receptor Gene Polymorphism Is Associated with Graves' Disease in the Japanese Population J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4639 - 4643. [Abstract] [Full Text]

				T. B. DRÜEKE Cell Biology of Parathyroid Gland Hyperplasia in Chronic Renal Failure J. Am. Soc. Nephrol., June 1, 2000; 11(6): 1141 - 1152. [Full Text]

				T. Carling, J. Rastad, E. Szabó, G. Westin, and G. Åkerström Reduced Parathyroid Vitamin D Receptor Messenger Ribonucleic Acid Levels in Primary and Secondary Hyperparathyroidism J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 2000 - 2003. [Abstract] [Full Text]

				S. B. Brown, T. T. Brierley, N. Palanisamy, I. B. Salusky, W. Goodman, M. L. Brandi, T. B. Drüeke, E. Sarfati, P. Ureña, R. S. K. Chaganti, et al. Vitamin D Receptor as a Candidate Tumor-Suppressor Gene in Severe Hyperparathyroidism of Uremia J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 868 - 872. [Abstract] [Full Text]

				J. A. Eisman Genetics of Osteoporosis Endocr. Rev., December 1, 1999; 20(6): 788 - 804. [Abstract] [Full Text]

				T. NIIMI, H. TOMITA, S. SATO, H. KAWAGUCHI, K. AKITA, H. MAEDA, Y. SUGIURA, and R. UEDA Vitamin D Receptor Gene Polymorphism in Patients with Sarcoidosis Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1107 - 1109. [Abstract] [Full Text]

				S. Ferrari, D. Manen, J.-P. Bonjour, D. Slosman, and R. Rizzoli Bone Mineral Mass and Calcium and Phosphate Metabolism in Young Men: Relationships with Vitamin D Receptor Allelic Polymorphisms J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2043 - 2048. [Abstract] [Full Text]

				P. Correa, J. Rastad, P. Schwarz, G. Westin, A. Kindmark, E. Lundgren, G. Åkerström, and T. Carling The Vitamin D Receptor (VDR) Start Codon Polymorphism in Primary Hyperparathyroidism and Parathyroid VDR Messenger Ribonucleic Acid Levels J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1690 - 1694. [Abstract] [Full Text]